Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chapman

Showing results (191-200 of 345) with videos related to

Pageof 35
Sort By:
Arthritis and Rheumatism|January 30, 2010
Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapyLisa K Stamp, John L O'Donnell, Peter T Chapman, et al.
Biochemistry|April 5, 1994
Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketonesN A Thornberry, E P Peterson, J J Zhao, et al.
Arthritis Research & Therapy|December 23, 2017
The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Rheumatology (Oxford, England)|August 15, 2018
Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|January 11, 2007
Two simple leg net devices designed to protect lower-extremity skin grafts and donor sites and prevent decubitus ulcerTravis L Hedman, Ted T Chapman, William S Dewey, et al.
Arthritis and Rheumatism|August 1, 2009
Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatmentLisa K Stamp, John L O'Donnell, Peter T Chapman, et al.
Gene Therapy|April 21, 2001
Expansion of tropism of a feline parvovirus to target a human tumor cell line by display of an alpha(v) integrin binding peptide on the capsidI H Maxwell, J T Chapman, L C Scherrer, et al.
Australian Veterinary Journal|June 17, 2005
Rapid identification of virulence genes in enterotoxigenic Escherichia coli isolates associated with diarrhoea in Queensland piggeriesT Do, C Stephens, K Townsend, et al.
Arthritis Research & Therapy|November 18, 2018
How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based doseLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
Annals of the Rheumatic Diseases|March 19, 2017
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with goutLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
Pageof 35

Showing results (191-200 of 345) with videos related to

Sort By:
Pageof 35
Arthritis and Rheumatism|January 30, 2010
Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapyLisa K Stamp, John L O'Donnell, Peter T Chapman, et al.
Biochemistry|April 5, 1994
Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketonesN A Thornberry, E P Peterson, J J Zhao, et al.
Arthritis Research & Therapy|December 23, 2017
The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Rheumatology (Oxford, England)|August 15, 2018
Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|January 11, 2007
Two simple leg net devices designed to protect lower-extremity skin grafts and donor sites and prevent decubitus ulcerTravis L Hedman, Ted T Chapman, William S Dewey, et al.
Arthritis and Rheumatism|August 1, 2009
Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatmentLisa K Stamp, John L O'Donnell, Peter T Chapman, et al.
Gene Therapy|April 21, 2001
Expansion of tropism of a feline parvovirus to target a human tumor cell line by display of an alpha(v) integrin binding peptide on the capsidI H Maxwell, J T Chapman, L C Scherrer, et al.
Australian Veterinary Journal|June 17, 2005
Rapid identification of virulence genes in enterotoxigenic Escherichia coli isolates associated with diarrhoea in Queensland piggeriesT Do, C Stephens, K Townsend, et al.
Arthritis Research & Therapy|November 18, 2018
How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based doseLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
Annals of the Rheumatic Diseases|March 19, 2017
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with goutLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
Pageof 35